Skip to content

English
Français

Careers
Contact Us

About DBV
- Overview
- Leadership
Our Pipeline
- Overview
- Clinical Trials
- VIASKIN^® peanut patch
- VIASKIN^® milk patch
- VIASKIN^® milk patch for EoE
- Expanded Access Program
Our Science
Investors
Newsroom
- Press Releases
- Media Kit

News

News

Select Year
Search News

Found 490 Results

Page 9 of 49« First «...7 8910 11...20 30 40...»Last »

January 16, 2024

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

December 4, 2023

Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023

November 9, 2023

DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers

November 6, 2023

Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023

November 2, 2023

DBV Technologies to Present New Data at ACAAI 2023

October 31, 2023

DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results

October 27, 2023

DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update

October 16, 2023

DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer

October 5, 2023

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023

September 5, 2023

DBV Technologies to Participate in Upcoming Investor Conference

Page 9 of 49« First «...7 8910 11...20 30 40...»Last »

Investor Relations Contact

Jonathan Neely

+1 848-388-4584

jonathan.neely@dbv-technologies.com

Media Contact

Brett Whelan

+1 848-350-7622

brett.whelan@dbv-technologies.com

Subscribe to get the latest DBV press releases

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

Homepage
About DBV
Our Pipeline
Our Science
News
Investors
Careers
Contact Us

© 2026 DBV Technologies. All rights reserved.
Les traitements de DBV Technologies sont expérimentaux et ne sont pas approuvés par la FDA.

Terms of Use
Privacy Policy
Legal Notice
Your California Privacy Rights

Scroll to Top